In July 2018, Calypso was awarded one of the 13 coveted Phase II Grower/Processor licenses through the Pennsylvania Medical Marijuana Program. With this exciting news, construction of a 100,000 square foot state-of-the-art facility commenced. This was no easy task during the winter months in Erie; however, with the commitment, support, and exhaustive labors from Calypso team members and partners, they established their roots.
Today, Calypso is working to create the next generation of marijuana products by continuously improving standards of operation, empowering employees, and embracing the community. Through compassion, innovation and excellence, Calypso Enterprises is dedicated to providing the highest quality medical marijuana products to those in the Commonwealth who suffer from chronic conditions.